Sunnybrook Health Sciences Centre: Prostatic Neoplasms trials

The registry lists 35 Prostatic Neoplasms studies with Sunnybrook Health Sciences Centre as lead sponsor. 6 are open to participants now and 3 have results posted.

Phase 1 8Phase 2 10Phase 3 1No phase 23(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate CancerNot yet recruitingNCT07512076Phase 2
• Pilot Study of Dose Escalation in Prostate Radiotherapy Using the MR-Linac (DESTINATION-MRL)RecruitingNCT06177093Not applicable
• Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate CancerRecruitingNCT05600400Not applicable
• Using Rectal Hydrogel Spacer for Salvage SABR in Prostate CancerRecruitingNCT05597852Not applicable
• Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate CancerRecruitingNCT04838899Not applicable
• 2 Ablative RadioTherapy Treatments for Prostate CancerRecruitingNCT04654338Phase 2/3
• Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRICompletedNCT05220501Not applicableResults posted
• Impact on Instructional Video on Patients' Compliance With Preparation During CT Planning for Prostate CancerCompletedNCT02410291Not applicableResults posted
• Hypofractionated Accelerated Radiotherapy for Low Risk Localized Prostate CancerCompletedNCT01578902Not applicableResults posted
• Dose-dEscalated MR-Guided Radiotherapy for Localized Prostate CancerActive, not recruitingNCT07674225Not applicable
• Stereotactic Body Radiotherapy (SBRT) Post ProstatectomyActive, not recruitingNCT04848909Not applicable
• Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate CancerActive, not recruitingNCT04619069Phase 1/2
• 5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:Status unknownNCT04245670Not applicable
• Trial of Hypofractionated IMRT Boost Versus Conventional IMRT Boost for Localized High Risk Prostate CancerStatus unknownNCT04239599Not applicable
• Stereotactic Pelvic Brachytherapy With HDR Boost for Dose Escalation in High Tier Intermediate and High Risk Prostate caStatus unknownNCT04236752Not applicable
• Post-Prostatectomy Linac-Based Ultrahypofractionated Radiotherapy for Patients With Localized Prostate CancerActive, not recruitingNCT04067570Not applicable
• Stereotactic MRI-Guided Radiation for Localized Prostate CancerStatus unknownNCT03588819Not applicable
• Combined LDR Boost and HDR Whole GlandTerminatedNCT03323879Phase 1/2
• Machine-learning Optimization for Prostate Brachytherapy PlanningCompletedNCT02943824Not applicable
• Hyperpolarized Carbon-13 Imaging of Metastatic Prostate CancerTerminatedNCT02844647Phase 1
• MRI Versus PSA in Prostate Cancer ScreeningStatus unknownNCT02799303Not applicable
• Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) InjectionWithdrawnNCT02647983Phase 1
• MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer PatientsActive, not recruitingNCT02623933Not applicable
• Stereotactic Radiotherapy for Oligometastatic Prostate CancerStatus unknownNCT02563691Phase 1/2
• Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate CancerActive, not recruitingNCT02560181Not applicable
• CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate CancerStatus unknownNCT02037464Phase 2
• SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN)Status unknownNCT01953055Phase 1/2
• The Value of MultiSpectral 3 Tesla MRI in Active Surveillance of Prostate CancerCompletedNCT01896713Not applicable
• A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate CancerStatus unknownNCT01890096Phase 2
• Multiparametric MRI for Prostate Cancer Localization and Characterization: New MethodsTerminatedNCT01761812Not applicable
• Focal Salvage HDR Brachytherapy for the Treatment of Prostate CancerActive, not recruitingNCT01583920Not applicable
• Response of Patients on Surveillance for Prostate Cancer to DutasterideCompletedNCT01525914
• Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate CancerStatus unknownNCT01505075Phase 1/2
• Conventional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer PatientsCompletedNCT01401972
• Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate CancerCompletedNCT01146340Phase 1/2